Search

Abigail Louise Vanhorn

Examiner (ID: 16074)

Most Active Art Unit
1616
Art Unit(s)
1616, 1609, 1636
Total Applications
1398
Issued Applications
583
Pending Applications
147
Abandoned Applications
713

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17312629 [patent_doc_number] => 20210401677 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-30 [patent_title] => DISSOLVABLE SOLID FIBROUS ARTICLES CONTAINING ANIONIC SURFACTANTS [patent_app_type] => utility [patent_app_number] => 17/357119 [patent_app_country] => US [patent_app_date] => 2021-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24676 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17357119 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/357119
DISSOLVABLE SOLID FIBROUS ARTICLES CONTAINING ANIONIC SURFACTANTS Jun 23, 2021 Abandoned
Array ( [id] => 17255807 [patent_doc_number] => 20210368792 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-02 [patent_title] => ANTI-MICROBIAL AGENT TO CONTROL BIOMASS ACCUMULATION IN SO2 SCRUBBERS [patent_app_type] => utility [patent_app_number] => 17/304480 [patent_app_country] => US [patent_app_date] => 2021-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16075 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17304480 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/304480
Anti-microbial agent to control biomass accumulation in SO Jun 21, 2021 Issued
Array ( [id] => 18511656 [patent_doc_number] => 20230227834 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-20 [patent_title] => Plasmid Copy Number Regulation and Integration [patent_app_type] => utility [patent_app_number] => 18/002055 [patent_app_country] => US [patent_app_date] => 2021-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24442 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18002055 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/002055
Plasmid Copy Number Regulation and Integration Jun 16, 2021 Pending
Array ( [id] => 18511656 [patent_doc_number] => 20230227834 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-20 [patent_title] => Plasmid Copy Number Regulation and Integration [patent_app_type] => utility [patent_app_number] => 18/002055 [patent_app_country] => US [patent_app_date] => 2021-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24442 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18002055 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/002055
Plasmid Copy Number Regulation and Integration Jun 16, 2021 Pending
Array ( [id] => 18485241 [patent_doc_number] => 20230212572 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-06 [patent_title] => Guanosine Analogues for Use in Therapeutics Polynucleotides [patent_app_type] => utility [patent_app_number] => 18/001098 [patent_app_country] => US [patent_app_date] => 2021-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14111 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -44 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18001098 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/001098
Guanosine Analogues for Use in Therapeutics Polynucleotides Jun 7, 2021 Pending
Array ( [id] => 17312713 [patent_doc_number] => 20210401761 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-30 [patent_title] => WATER-SOLUBLE LUTEIN ESTER MICROCAPSULES AND A METHOD OF PREPARING THE SAME [patent_app_type] => utility [patent_app_number] => 17/340292 [patent_app_country] => US [patent_app_date] => 2021-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2947 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17340292 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/340292
Water-soluble lutein ester microcapsules and a method of preparing the same Jun 6, 2021 Issued
Array ( [id] => 17126212 [patent_doc_number] => 20210300980 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-30 [patent_title] => OSTEOGENIC BIOMATERIAL [patent_app_type] => utility [patent_app_number] => 17/340405 [patent_app_country] => US [patent_app_date] => 2021-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6514 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17340405 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/340405
Osteogenic biomaterial Jun 6, 2021 Issued
Array ( [id] => 17256786 [patent_doc_number] => 20210369771 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-02 [patent_title] => PHARMACEUTICAL OR FOOD SUPPLEMENT FORMULATION FOR USE IN TREATING DISORDERS CAUSED BY IRON DEFICIENCY [patent_app_type] => utility [patent_app_number] => 17/319297 [patent_app_country] => US [patent_app_date] => 2021-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3517 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17319297 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/319297
PHARMACEUTICAL OR FOOD SUPPLEMENT FORMULATION FOR USE IN TREATING DISORDERS CAUSED BY IRON DEFICIENCY May 12, 2021 Abandoned
Array ( [id] => 18451986 [patent_doc_number] => 20230193265 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-22 [patent_title] => CUG REPEAT SEQUENCE BINDING AGENT [patent_app_type] => utility [patent_app_number] => 17/925225 [patent_app_country] => US [patent_app_date] => 2021-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7209 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17925225 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/925225
CUG REPEAT SEQUENCE BINDING AGENT May 11, 2021 Pending
Array ( [id] => 17051164 [patent_doc_number] => 20210260598 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-26 [patent_title] => PRODUCTION OF ENCAPSULATED NANOPARTICLES AT COMMERCIAL SCALE [patent_app_type] => utility [patent_app_number] => 17/318983 [patent_app_country] => US [patent_app_date] => 2021-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37389 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17318983 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/318983
PRODUCTION OF ENCAPSULATED NANOPARTICLES AT COMMERCIAL SCALE May 11, 2021 Abandoned
Array ( [id] => 17228428 [patent_doc_number] => 20210354984 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-18 [patent_title] => COMPOSITIONS OF POLYMERIC MICRODEVICES AND METHODS OF USE THEREOF IN CANCER IMMUNOTHERAPY [patent_app_type] => utility [patent_app_number] => 17/317335 [patent_app_country] => US [patent_app_date] => 2021-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25577 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -34 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17317335 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/317335
Compositions of polymeric microdevices and methods of use thereof in cancer immunotherapy May 10, 2021 Issued
Array ( [id] => 18583252 [patent_doc_number] => 20230265512 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-24 [patent_title] => METHOD FOR DIAGNOSING DOWN'S SYNDROME BY USING DOWN'S SYNDROME-SPECIFIC EPIGENETIC MARKER [patent_app_type] => utility [patent_app_number] => 18/003609 [patent_app_country] => US [patent_app_date] => 2021-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8531 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 461 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18003609 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/003609
METHOD FOR DIAGNOSING DOWN'S SYNDROME BY USING DOWN'S SYNDROME-SPECIFIC EPIGENETIC MARKER May 6, 2021 Pending
Array ( [id] => 18583252 [patent_doc_number] => 20230265512 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-24 [patent_title] => METHOD FOR DIAGNOSING DOWN'S SYNDROME BY USING DOWN'S SYNDROME-SPECIFIC EPIGENETIC MARKER [patent_app_type] => utility [patent_app_number] => 18/003609 [patent_app_country] => US [patent_app_date] => 2021-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8531 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 461 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18003609 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/003609
METHOD FOR DIAGNOSING DOWN'S SYNDROME BY USING DOWN'S SYNDROME-SPECIFIC EPIGENETIC MARKER May 6, 2021 Pending
Array ( [id] => 18452037 [patent_doc_number] => 20230193316 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-22 [patent_title] => ENGINEERED CENTRAL NERVOUS SYSTEM COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 17/922437 [patent_app_country] => US [patent_app_date] => 2021-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 77457 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -91 [patent_words_short_claim] => 152 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17922437 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/922437
ENGINEERED CENTRAL NERVOUS SYSTEM COMPOSITIONS Apr 29, 2021 Pending
Array ( [id] => 17183026 [patent_doc_number] => 20210329911 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-28 [patent_title] => AEROSOL SPRAYER FOR INSECT PEST MATING DISRUPTION [patent_app_type] => utility [patent_app_number] => 17/243113 [patent_app_country] => US [patent_app_date] => 2021-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5028 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17243113 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/243113
Aerosol sprayer for insect pest mating disruption Apr 27, 2021 Issued
Array ( [id] => 18485249 [patent_doc_number] => 20230212582 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-06 [patent_title] => COMPOSITIONS OF SMAD7 ANTISENSE OLIGONUCLEOTIDES (ASO) AND METHODS OF USING THE SAME [patent_app_type] => utility [patent_app_number] => 17/996505 [patent_app_country] => US [patent_app_date] => 2021-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25518 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -77 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17996505 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/996505
COMPOSITIONS OF SMAD7 ANTISENSE OLIGONUCLEOTIDES (ASO) AND METHODS OF USING THE SAME Apr 22, 2021 Pending
Array ( [id] => 18496009 [patent_doc_number] => 20230218536 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-13 [patent_title] => NANOPARTICLES CONTAINING COMPLEXES OF NUCLEIC ACIDS AND CATIONIC COPOLYMERS, PROCESS FOR PREPARING THEM AND THEIR USE FOR GENE TRANSFER IN CELLS [patent_app_type] => utility [patent_app_number] => 17/996435 [patent_app_country] => US [patent_app_date] => 2021-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12506 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17996435 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/996435
NANOPARTICLES CONTAINING COMPLEXES OF NUCLEIC ACIDS AND CATIONIC COPOLYMERS, PROCESS FOR PREPARING THEM AND THEIR USE FOR GENE TRANSFER IN CELLS Apr 13, 2021 Pending
Array ( [id] => 18921509 [patent_doc_number] => 20240024513 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-25 [patent_title] => NUCLEIC ACIDS ENCODING HUMAN FUS PROTEIN AND USE IN THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS) [patent_app_type] => utility [patent_app_number] => 17/915569 [patent_app_country] => US [patent_app_date] => 2021-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11955 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17915569 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/915569
NUCLEIC ACIDS ENCODING HUMAN FUS PROTEIN AND USE IN THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS) Apr 8, 2021 Pending
Array ( [id] => 17095524 [patent_doc_number] => 20210283315 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-16 [patent_title] => DRUG RELEASING COATINGS FOR MEDICAL DEVICES [patent_app_type] => utility [patent_app_number] => 17/223641 [patent_app_country] => US [patent_app_date] => 2021-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32016 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17223641 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/223641
DRUG RELEASING COATINGS FOR MEDICAL DEVICES Apr 5, 2021 Abandoned
Array ( [id] => 17398291 [patent_doc_number] => 20220040381 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-10 [patent_title] => METHODS AND POLYMER-CONTAINING FORMULATIONS FOR TREATING RETINAL DETACHMENT AND OTHER OCULAR DISORDERS [patent_app_type] => utility [patent_app_number] => 17/217132 [patent_app_country] => US [patent_app_date] => 2021-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16097 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17217132 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/217132
METHODS AND POLYMER-CONTAINING FORMULATIONS FOR TREATING RETINAL DETACHMENT AND OTHER OCULAR DISORDERS Mar 29, 2021 Abandoned
Menu